Scott C. Brun's most recent trade in Cabaletta Bio Inc was a trade of 22,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cabaletta Bio Inc | Scott C. Brun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Forte Biosciences Inc | Scott C. Brun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2026 | 18,353 | 18,353 | - | - | Restricted Stock Units | |
| Jasper Therapeutics Inc | Scott C. Brun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Cabaletta Bio Inc | Scott C. Brun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Scott C. Brun | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 44,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Scott C. Brun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Scott C. Brun | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 22,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Scott C. Brun | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 May 2025 | 22,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Scott C. Brun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Cabaletta Bio Inc | Scott C. Brun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Forte Biosciences Inc | Scott C. Brun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 31,000 | 31,000 | - | - | Stock Option (right to buy) | |
| Forte Biosciences Inc | Scott C. Brun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Jasper Therapeutics Inc | Scott C. Brun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Cabaletta Bio Inc | Scott C. Brun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Jasper Therapeutics Inc | Scott C. Brun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 94,000 | 94,000 | - | - | Stock Option (right to buy) | |
| Cabaletta Bio Inc | Scott C. Brun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Forte Biosciences Inc | Scott C. Brun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2022 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Cabaletta Bio Inc | Scott C. Brun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) |